Literature DB >> 16797032

Cellular action of cholecystokinin-8S-mediated excitatory effects in the rat periaqueductal gray.

Yu-Mi Yang1, Jun-Mo Chung, Hyewhon Rhim.   

Abstract

The peptide cholecystokinin (CCK) is one of the major neurotransmitters modulating satiety, nociception, and anxiety behavior. Although many behavioral studies showing anti-analgesic and anxiogenic actions of CCK have been reported, less is known about its cellular action in the central nervous system (CNS). Therefore, we examined the action of CCK in rat dorsolateral periaqueductal gray (PAG) neurons using slice preparations and whole-cell patch-clamp recordings. Application of CCK-8S produced an inward current accompanied by increased spontaneous synaptic activities. The CCK-8S-induced inward current (I(CCK)) was recovered after washout and reproduced by multiple exposures. Current-voltage plots revealed that I(CCK) reversed near the equilibrium potential for K(+) ions with a decreased membrane conductance. When several K(+) channel blockers were used, application of CdCl(2), TEA, or apamin significantly reduced I(CCK). I(CCK) was also significantly reduced by the CCK(2) receptor antagonist, L-365,260, while it was not affected by the CCK(1) receptor antagonist, L-364,718. Furthermore, we examined the effects of CCK-8S on miniature excitatory postsynaptic currents (mEPSCs) in order to determine the mechanism of CCK-mediated increase on synaptic activities. We found that CCK-8S increased the frequency of mEPSCs, but had no effect on mEPSC amplitude. This presynaptic effect persisted in the presence of CdCl(2) or Ca(2+)-free bath solution, but was completely abolished by pre-treatment with BAPTA-AM, thapsigargin or L-365,260. Taken together, our results indicate that CCK can excite PAG neurons at both pre- and postsynaptic loci via the activation of CCK(2) receptors. These effects may be important for the effects of CCK on behavior and autonomic function that are mediated via PAG neurons.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16797032     DOI: 10.1016/j.lfs.2006.05.027

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

1.  Pharmacological investigations of the cellular transduction pathways used by cholecystokinin to activate nodose neurons.

Authors:  Huan Zhao; Dallas C Kinch; Steven M Simasko
Journal:  Auton Neurosci       Date:  2011-06-12       Impact factor: 3.145

2.  Cholecystokinin exerts an effect via the endocannabinoid system to inhibit GABAergic transmission in midbrain periaqueductal gray.

Authors:  Vanessa A Mitchell; Hyo-Jin Jeong; Geoffrey M Drew; Christopher W Vaughan
Journal:  Neuropsychopharmacology       Date:  2011-04-27       Impact factor: 7.853

3.  Sparse genetically defined neurons refine the canonical role of periaqueductal gray columnar organization.

Authors:  Mimi Q La-Vu; Ekayana Sethi; Sandra Maesta-Pereira; Peter J Schuette; Brooke C Tobias; Fernando M C V Reis; Weisheng Wang; Anita Torossian; Amy Bishop; Saskia J Leonard; Lilly Lin; Catherine M Cahill; Avishek Adhikari
Journal:  Elife       Date:  2022-06-08       Impact factor: 8.713

4.  Spinal CCK contributes to somatic hyperalgesia induced by orofacial inflammation combined with stress in adult female rats.

Authors:  Lu-Lu Duan; Xin-Yi Qiu; Si-Qi Wei; Han-Yu Su; Fu-Rong Bai; Richard J Traub; Qin Zhou; Dong-Yuan Cao
Journal:  Eur J Pharmacol       Date:  2021-11-05       Impact factor: 5.195

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.